Top in cardiology: Atherosclerosis common in lung cancer; treating amyloidosis
Patients beginning lung cancer treatment demonstrated a high prevalence of atherosclerosis, which suggests that they may benefit from calcium scoring, new data showed.
According to a presentation given at the American College of Cardiology’s Advancing theCardiovascular Care of the Oncology Patient course, more than three-quarters of patients entering lung cancer treatment who underwent chest CT imaging showed evidence of atherosclerosis.
White patients who smoked appeared most likely to have atherosclerosis on CT out of all the subgroups examined, researchers found.
“What this study confirms is that tobacco use is a shared risk factor for both diseases and at the time of lung cancer diagnosis these patients should be considered for additional evaluation by a cardiologist or cardio-oncologist, as it is likely they already have CV disease,” Christopher Malozzi, DO, director of cardio-oncology services at the University of South Alabama Frederick P. Whiddon College of Medicine, told Healio.
It was the top story in cardiology last week.
In another top story, Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, discussed the evolving treatment landscape of amyloidosis.
Read these and more top stories in cardiology below:
High prevalence of atherosclerosis detected in patients entering lung cancer therapy
CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course. Read more.
Navigating the treatment landscape in amyloidosis
In this audio clip, Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, talks about treatment options for amyloidosis. Listen here.
VIDEO: AI has potential 'huge role' in amyloidosis
In this video, Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, discusses potential uses for AI in the amyloidosis space. Watch here.
Q&A: When diagnosing and managing amyloidosis, 'the earlier the better'
Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients with amyloidosis, early screening and more. Read more.
An ‘asterisk population’: Poor data complicate maternal health research for Native women
American Indian and Alaska Native women have some of the highest rates of maternal death and morbidity in the United States, yet challenges with poor data collection continue to complicate efforts to improve health outcomes. Read more.